Bulk anda single-cell transcriptome profiling reveals the molecular characteristics of T cell-mediated tumor killing

Yin-Wei Dai1, Ya-Ting Pan2, Dan-Feng Lin1

  • 1Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Heliyon
|March 7, 2024
PubMed
Abstract

Insights

Identifying patient subgroups is key for pancreatic adenocarcinoma (PAAD) immune checkpoint blockade (ICB) success. This study reveals distinct T cell-mediated tumor killing (TTK) patterns in PAAD, aiding personalized immunotherapy strategies.

Area of Science:

  • Immunology
  • Oncology
  • Genetics

Background:

  • Immune checkpoint blockade (ICB) shows promise for pancreatic adenocarcinoma (PAAD), but patient stratification is needed.
  • T cell-mediated tumor killing (TTK) is central to ICB efficacy.
  • Identifying specific PAAD patient subgroups likely to benefit from ICB is crucial.

Purpose of the Study:

  • To explore PAAD subtypes based on genes associated with TTK sensitivity.
  • To understand the link between TTK-related genes and PAAD immunotherapy response.
  • To develop a predictive scoring system for immunotherapy sensitivity in PAAD.

Main Methods:

  • Examined genes controlling T cell-induced tumor destruction (GSTTK) in PAAD.
  • Utilized unsupervised clustering to divide PAAD samples into two subsets based on GSTTK.
  • Developed and validated the TRGscore for predicting immunotherapy and chemotherapeutic response.

Main Results:

  • Identified two PAAD clusters with distinct TTK patterns, prognostic relevance, and immune microenvironment characteristics.
  • Observed significant differences in survival, immune cell infiltration, and immunotherapy response between clusters.
  • The TRGscore accurately predicted patient response to immunotherapy and chemotherapy, and overall survival.

Conclusions:

  • TTK significantly impacts the tumor immune microenvironment (TIME) in PAAD.
  • Understanding variations in TTK modes enhances knowledge of TIME characteristics.
  • This research provides insights into T cell function in PAAD, guiding improved treatment strategies.

Related Concept Videos